Who
Westlake BioPartners Fund I, L.P.
10% owner
Company insider
Files Form 4 as: 10% owner, Latigo Biotherapeutics.
In numbers
- Trades disclosed
- 14
- Buys
- 0
- Sells
- 0
- Bought
- $0
- Sold
- $0
- Companies
- 1
- Companies where not an officer
- 1
- First trade
- 10 Aug 2026
- Last trade
- 10 Aug 2026
- Last filed
- 11 Aug 2026
Companies traded
Activity over time
Not enough dated trades to draw.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 10 Aug 2026filed 11 Aug 2026 | LTGO Latigo BiotherapeuticsBiotechnology | SEC FORM 4 Code C | —938,979 | filing |
| 10 Aug 2026filed 11 Aug 2026 | LTGO Latigo Biotherapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code C | —1,027,635 | filing |
| 10 Aug 2026filed 11 Aug 2026 | LTGO Latigo Biotherapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code C | —3,464,072 | filing |
| 10 Aug 2026filed 11 Aug 2026 | LTGO Latigo Biotherapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code C | —1,484,401 | filing |
| 10 Aug 2026filed 11 Aug 2026 | LTGO Latigo Biotherapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code C | —2,066,857 | filing |
| 10 Aug 2026filed 11 Aug 2026 | LTGO Latigo Biotherapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code C | —165,519 | filing |
| 10 Aug 2026filed 11 Aug 2026 | LTGO Latigo BiotherapeuticsBiotechnology | SEC FORM 4 Code C | —3,547,842 | filing |
| 10 Aug 2026filed 11 Aug 2026 | LTGO Latigo BiotherapeuticsBiotechnology | SEC FORM 4 Code C | —1,027,635 | filing |
| 10 Aug 2026filed 11 Aug 2026 | LTGO Latigo BiotherapeuticsBiotechnology | SEC FORM 4 Code C | —3,464,072 | filing |
| 10 Aug 2026filed 11 Aug 2026 | LTGO Latigo BiotherapeuticsBiotechnology | SEC FORM 4 Code C | —1,484,401 | filing |
| 10 Aug 2026filed 11 Aug 2026 | LTGO Latigo BiotherapeuticsBiotechnology | SEC FORM 4 Code C | —165,519 | filing |
| 10 Aug 2026filed 11 Aug 2026 | LTGO Latigo BiotherapeuticsBiotechnology | SEC FORM 4 Code C | —2,066,857 | filing |
| 10 Aug 2026filed 11 Aug 2026 | LTGO Latigo Biotherapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code C | —938,979 | filing |
| 10 Aug 2026filed 11 Aug 2026 | LTGO Latigo Biotherapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code C | —3,547,842 | filing |
News
No headline names them, or the companies they trade most, lately.
Sectors
No trade we could place in a sector.